J0209 HCPCS Level II Code: Injection, sodium thiosulfate (hope), 100 mg
Medicare Coverage & Payment
- CMS short descriptor: Inj, sod thiosulfate (hope)
- Medicare coverage: Carrier judgment (CMS coverage code C)
- Payment category: Drugs (pricing indicator 51)
- BETOS: O1E — Other drugs
- Last CMS action effective: January 1, 2026
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Change history
- April 1, 2024Added to the code setInjection, sodium thiosulfate (hope), 100 mg
Contextual Map
Every relationship of J0209 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Nearest codes (36)
- J0200 — Injection, alatrofloxacin mesylate, 100 mg[Sibling]
- J0202 — Injection, alemtuzumab, 1 mg[Sibling]
- J0205 — Injection, alglucerase, per 10 units[Sibling]
- J0206 — Injection, allopurinol sodium, 1 mg[Sibling]
- J0207 — Injection, amifostine, 500 mg[Sibling]
- J0208 — Injection, sodium thiosulfate (pedmark), 100 mg[Sibling]
- J0210 — Injection, methyldopate hcl, up to 250 mg[Sibling]
- J0211 — Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)[Sibling]
- and 28 more
Change history
- April 1, 2024 — Added to the code set [Change history]
Nearest Codes in This Family
Official HCPCS Level II classifications closest to J0209 in its code family, with their registry titles.
- J0202 — Injection, alemtuzumab, 1 mg
- J0205 — Injection, alglucerase, per 10 units
- J0206 — Injection, allopurinol sodium, 1 mg
- J0207 — Injection, amifostine, 500 mg
- J0208 — Injection, sodium thiosulfate (pedmark), 100 mg
- J0210 — Injection, methyldopate hcl, up to 250 mg
- J0211 — Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)
- J0215 — Injection, alefacept, 0.5 mg
- J0216 — Injection, alfentanil hydrochloride, 500 micrograms
- J0217 — Injection, velmanase alfa-tycv, 1 mg